Ticker Short Interest

NBIX Short Interest Intelligence

Neurocrine Biosciences Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

NBIX is classified as Neutral. Latest reported short interest is 5.5M shares; short interest changed -2.8%, price moved +5.5% since the previous report, short interest is in the 57th percentile, and days to cover is in the 29th percentile. Trend context is constructive.

Setup Score44/100Neutral
Reported Short Interest5.5M-2.8% vs prior report
Days To Cover4.2028.57 percentile
Price Reaction+5.5%since previous short report
Squeeze Pressure44crowding, trend, and pressure
Bearish Conviction19shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

44

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

19

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

44

Latest short interest is 5.5M shares and days to cover is 4.20.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

NBIX Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 5530854 5690488 -2.8% 4.20 1315407
15 Jun 2026 5690488 5529509 2.9% 5.04 1128101
29 May 2026 5529509 5160707 7.2% 4.96 1114763
15 May 2026 5160707 5992527 -13.9% 3.69 1400192
30 Apr 2026 5992527 5644452 6.2% 5.15 1163604
15 Apr 2026 5644452 4557132 23.9% 4.86 1160869
31 Mar 2026 4557132 3858266 18.1% 4.64 982231

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.